Identification of microRNA-mRNA dysregulations in paroxysmal atrial fibrillation

David Y Chiang1, Min Zhang2, Niels Voigt3

  • 1Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX, USA; Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX, USA.

Abstract

Insights

This study reveals novel molecular pathways and microRNA-messenger RNA interactions involved in early atrial fibrillation (AF) development. Understanding these epigenetic changes, like miR-199a-5p and FKBP5, is key for future AF therapies.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Epigenetics

Background:

  • The molecular basis of early atrial fibrillation (AF) development, particularly paroxysmal AF (pAF), is not fully understood.
  • Emerging research suggests microRNAs (miRNAs) play a role in pAF pathogenesis through epigenetic modifications.

Purpose of the Study:

  • To identify molecular alterations driving pAF by investigating abnormal miRNA-mRNA interactions.
  • To uncover key molecular changes associated with the early stages of AF.

Main Methods:

  • RNA sequencing and miRNA microarray analysis of atrial biopsies from pAF patients and sinus rhythm (SR) controls.
  • Bioinformatic analysis to identify differentially expressed genes and miRNAs, and predict miRNA-mRNA interactions.
  • Validation of predicted interactions using quantitative real-time PCR (qRT-PCR) and 3'UTR luciferase reporter assays.

Main Results:

  • 113 genes and 49 miRNAs were differentially expressed between pAF and SR groups.
  • Key pathways identified include the gonadotropin releasing hormone receptor and p53 pathways.
  • Confirmed a specific interaction: upregulation of miR-199a-5p and downregulation of FKBP5 in pAF patients.

Conclusions:

  • Combined transcriptomic and miRNA analysis identified novel pathways and miRNA-mRNA regulations potentially involved in pAF development.
  • The gonadotropin releasing hormone receptor and p53 pathways warrant further investigation in AF pathogenesis.
  • This study provides new insights into the molecular mechanisms underlying early AF.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
855